Vnitr Lek 2004, 50(2):157-162
[Nimesulide: a lower risk treatment in rheumatic diseases].
Klíčová slova: Anti-Inflammatory Agents, Non-Steroidal, adverse effects, ; Cyclooxygenase Inhibitors, adverse effects, ; Humans; Rheumatic Diseases, drug therapy, ; Sulfonamides, adverse effects,
This review paper presents some basic information of a "rediscovered" nonsteroidal anti-inflammatory drug Nimesulid which is one of the first selective inhibitors of cyclooxygenase-2, has a history of good clinical results, and is relatively well tolerated with patients. Nimesulid enhances possible ways of analgesia treatment of rheumatic diseases.
Keywords: Anti-Inflammatory Agents, Non-Steroidal /adverse effects/; Cyclooxygenase Inhibitors /adverse effects/; Humans; Rheumatic Diseases /drug therapy/; Sulfonamides /adverse effects/
Zveřejněno: 1. únor 2004 Zobrazit citaci